Non-small cell lung cancer (NSCLC) is the leading cause of cancerrelated mortality worldwide. Platinum-based chemotherapy represents the main treatment, despite about the 70% of tumors are intrinsically resistant. Deciphering the mechanisms of platinum-resistance is urgently needed.
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance / Rampioni Vinciguerra, Gian Luca; Capece, Marina; Distefano, Rosario; Nigita, Giovanni; Vecchione, Andrea; Lovat, Francesca; Croce, Carlo M. - In: SIGNAL TRANSDUCTION AND TARGETED THERAPY. - ISSN 2059-3635. - 8:1(2023), pp. 1-4. [10.1038/s41392-022-01228-z]
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance
Rampioni Vinciguerra, Gian Luca;Vecchione, Andrea;
2023
Abstract
Non-small cell lung cancer (NSCLC) is the leading cause of cancerrelated mortality worldwide. Platinum-based chemotherapy represents the main treatment, despite about the 70% of tumors are intrinsically resistant. Deciphering the mechanisms of platinum-resistance is urgently needed.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
RampioniVinciguerra_Role-of the miR-301a/Fra-2/GLIPR1_2023.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
1.31 MB
Formato
Adobe PDF
|
1.31 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
